Associations of psychotic symptom dimensions with clinical and developmental variables in twin and general clinical samples.

Psychosis familial intelligence symptoms twins

Journal

The British journal of psychiatry : the journal of mental science
ISSN: 1472-1465
Titre abrégé: Br J Psychiatry
Pays: England
ID NLM: 0342367

Informations de publication

Date de publication:
30 Oct 2024
Historique:
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: aheadofprint

Résumé

Positive, negative and disorganised psychotic symptom dimensions are associated with clinical and developmental variables, but differing definitions complicate interpretation. Additionally, some variables have had little investigation. To investigate associations of psychotic symptom dimensions with clinical and developmental variables, and familial aggregation of symptom dimensions, in multiple samples employing the same definitions. We investigated associations between lifetime symptom dimensions and clinical and developmental variables in two twin and two general psychosis samples. Dimension symptom scores and most other variables were from the Operational Criteria Checklist. We used logistic regression in generalised linear mixed models for combined sample analysis ( Higher symptom scores on all three dimensions were associated with poor premorbid social adjustment, never marrying/cohabiting and earlier age at onset, and with a chronic course, most strongly for the negative dimension. The positive dimension was also associated with Black and minority ethnicity and lifetime cannabis use; the negative dimension with male gender; and the disorganised dimension with gradual onset, lower premorbid IQ and substantial within twin-pair correlation. In secondary analysis, disorganised symptoms in MZ twin probands were associated with lower premorbid IQ in their co-twins. These results confirm associations that dimensions share in common and strengthen the evidence for distinct associations of co-occurring positive symptoms with ethnic minority status, negative symptoms with male gender and disorganised symptoms with substantial familial influences, which may overlap with influences on premorbid IQ.

Sections du résumé

BACKGROUND BACKGROUND
Positive, negative and disorganised psychotic symptom dimensions are associated with clinical and developmental variables, but differing definitions complicate interpretation. Additionally, some variables have had little investigation.
AIMS OBJECTIVE
To investigate associations of psychotic symptom dimensions with clinical and developmental variables, and familial aggregation of symptom dimensions, in multiple samples employing the same definitions.
METHOD METHODS
We investigated associations between lifetime symptom dimensions and clinical and developmental variables in two twin and two general psychosis samples. Dimension symptom scores and most other variables were from the Operational Criteria Checklist. We used logistic regression in generalised linear mixed models for combined sample analysis (
RESULTS RESULTS
Higher symptom scores on all three dimensions were associated with poor premorbid social adjustment, never marrying/cohabiting and earlier age at onset, and with a chronic course, most strongly for the negative dimension. The positive dimension was also associated with Black and minority ethnicity and lifetime cannabis use; the negative dimension with male gender; and the disorganised dimension with gradual onset, lower premorbid IQ and substantial within twin-pair correlation. In secondary analysis, disorganised symptoms in MZ twin probands were associated with lower premorbid IQ in their co-twins.
CONCLUSIONS CONCLUSIONS
These results confirm associations that dimensions share in common and strengthen the evidence for distinct associations of co-occurring positive symptoms with ethnic minority status, negative symptoms with male gender and disorganised symptoms with substantial familial influences, which may overlap with influences on premorbid IQ.

Identifiants

pubmed: 39474930
doi: 10.1192/bjp.2024.129
pii: S0007125024001296
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-8

Subventions

Organisme : NIMH NIH HHS
ID : MH44359
Pays : United States
Organisme : Stanley Medical Research Institute
ID : n/a
Organisme : Wellcome Trust
ID : 064971
Pays : United Kingdom
Organisme : Wellcome Trust
ID : Personal Fellowship to J.A. (209176/Z/17/Z)
Pays : United Kingdom
Organisme : Wellcome Trust
ID : Value in People Award to A.G.C. (473588)
Pays : United Kingdom
Organisme : Psychiatry Research Trust
ID : n/a
Organisme : Medical Research Council
ID : Clinical Training Fellowship to A.G.C.
Pays : United Kingdom
Organisme : Medical Research Council
ID : Project Grant (MR/J004391/1)
Pays : United Kingdom
Organisme : Economic and Social Research Council
ID : PTA-037-27-0002
Organisme : National Alliance for Research on Schizophrenia and Depression
ID : Young Investigator Award to T.T.

Auteurs

Alastair G Cardno (AG)

Division of Psychological and Social Medicine, University of Leeds, Leeds, UK.

Judith Allardyce (J)

Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Steven C Bakker (SC)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Timothea Toulopoulou (T)

Department of Psychology and National Magnetic Resonance Research Center (UMRAM), Bilkent University, Ankara, Turkey.
Department of Psychiatry, National and Kapodistrian University of Athens, Athens, Greece.
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, USA.

Eugenia Kravariti (E)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Marco M Picchioni (MM)

Department of Forensic and Neurodevelopmental Science, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Fergus Kane (F)

Department of Clinical Educational and Health Psychology, University College London, London, UK.

Frühling V Rijsdijk (FV)

Psychology Department, Anton de Kom University of Suriname, Paramaribo, Suriname.
Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Tariq Mahmood (T)

Becklin Centre, Leeds & York Partnership NHS Foundation Trust, Leeds, UK.

Soumaya Nasser El Din (S)

Becklin Centre, Leeds & York Partnership NHS Foundation Trust, Leeds, UK.

Deline du Toit (D)

Cygnet Healthcare, Bradford, UK.

Lisa A Jones (LA)

Three Counties Medical School, University of Worcester, Worcester, UK.

Diego Quattrone (D)

Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

James T R Walters (JTR)

Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Sophie E Legge (SE)

Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Peter A Holmans (PA)

Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.

Robin M Murray (RM)

Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Evangelos Vassos (E)

Social, Genetic and Developmental Psychiatry (SGDP) Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Classifications MeSH